Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

BACKGROUND: Uveal melanoma (UM) is the most common intraocular malignancy in adults. In contrast to cutaneous melanoma (CM), there is no standard therapy, and the efficacy and safety of dual checkpoint blockade with nivolumab and ipilimumab is not well defined. METHODS: We conducted a retrospective...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunother Cancer
Autori principali: Najjar, Yana G, Navrazhina, Kristina, Ding, Fei, Bhatia, Roma, Tsai, Katy, Abbate, Kelly, Durden, Barbara, Eroglu, Zeynep, Bhatia, Shailender, Park, Song, Chowdhary, Akansha, Chandra, Sunandana, Kennedy, Jonathan, Puzanov, Igor, Ernstoff, Marc, Vachhani, Pankit, Drabick, Joseph, Singh, Arun, Xu, Tan, Yang, Jessica, Carvajal, Richard, Manson, Daniel, M Kirkwood, John, Cohen, Justine, Sullivan, Ryan, Johnson, Douglas, Funchain, Pauline, Shoushtari, Alexander
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Clinical/Translational Cancer Immunotherapy
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319717/
https://ncbi.nlm.nih.gov/pubmed/32581057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000331
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi